Paper Details

  1. Home
  2. Paper Details

Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients.

Author: BaldelliSara, BittoAlessandra, CattaneoDario, CortinovisMonica, GottiEliana, PericoNorberto, RemuzziGiuseppe

Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study explores the development of an enteric-coated formulation of mycophenolate sodium as an alternative to mycophenolate mofetil to improve graft survival after organ transplantation. While mycophenolate mofetil has proven beneficial, its side effects can be limiting. This formulation addresses those concerns, but further pharmacokinetic data on mycophenolic acid release is needed.
Paper Details　
Original Abstract of the Article :
The introduction of mycophenolate mofetil has improved graft survival after organ transplantation; however, its use may be limited by important adverse effects. For overcoming these problems, an enteric-coated formulation of mycophenolate sodium has been developed, but pharmacokinetic data of mycoph...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2215/CJN.02820707

データ提供：米国国立医学図書館（NLM）

Comparing Mycophenolate Sodium and Mofetil: A Quest for Improved Graft Survival

This research investigates the pharmacokinetics of mycophenolate sodium, a medication used to prevent organ rejection, and compares it to its sister drug, mycophenolate mofetil. The study focuses on patients who have received kidney transplants and are in a stable condition. The researchers sought to compare the absorption, distribution, metabolism, and elimination of mycophenolate sodium and mycophenolate mofetil to better understand their differences in terms of drug levels and efficacy. This research aims to inform clinical practice by providing a deeper understanding of these two drugs' pharmacokinetic profiles, potentially leading to improved treatment strategies for transplant recipients.

Mycophenolate Sodium: A Potential Alternative for Transplant Recipients

The study explores the pharmacokinetic profile of mycophenolate sodium, a promising alternative to mycophenolate mofetil for preventing organ rejection. The findings will provide clinicians with valuable information to guide treatment decisions for transplant recipients, potentially leading to improved outcomes and reduced side effects.

Navigating the World of Immunosuppressants

Organ transplantation is a life-saving procedure, but it requires careful management to prevent rejection. This research underscores the importance of choosing the right immunosuppressant medication, considering its pharmacokinetic properties and potential side effects. It's crucial to work closely with your transplant team to make informed decisions about your treatment plan.

Dr. Camel's Conclusion

This research, like a wise camel navigating a treacherous desert landscape, explores the pharmacokinetic properties of mycophenolate sodium. The study's findings offer a valuable roadmap for clinicians, helping them optimize treatment strategies for organ transplant recipients. It's a reminder that the journey to successful transplantation is a collaborative one, requiring careful consideration of treatment options and a commitment to improving patient outcomes.
Date :
  1. Date Completed 2007-11-20
  2. Date Revised 2016-11-24
Further Info :

Pubmed ID

17928466

DOI: Digital Object Identifier

10.2215/CJN.02820707

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.